These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35387508)

  • 1. Recommendations for the use of propensity score methods in multiple sclerosis research.
    Simoneau G; Pellegrini F; Debray TP; Rouette J; Muñoz J; Platt RW; Petkau J; Bohn J; Shen C; de Moor C; Karim ME
    Mult Scler; 2022 Aug; 28(9):1467-1480. PubMed ID: 35387508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review.
    Karim ME; Pellegrini F; Platt RW; Simoneau G; Rouette J; de Moor C
    Mult Scler; 2022 Aug; 28(9):1317-1323. PubMed ID: 33179573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review.
    Ali MS; Groenwold RH; Belitser SV; Pestman WR; Hoes AW; Roes KC; Boer Ad; Klungel OH
    J Clin Epidemiol; 2015 Feb; 68(2):112-21. PubMed ID: 25433444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bias associated with using the estimated propensity score as a regression covariate.
    Hade EM; Lu B
    Stat Med; 2014 Jan; 33(1):74-87. PubMed ID: 23787715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity score analysis methods with balancing constraints: A Monte Carlo study.
    Li Y; Li L
    Stat Methods Med Res; 2021 Apr; 30(4):1119-1142. PubMed ID: 33525962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applying Propensity Score Methods in Clinical Research in Neurology.
    Austin PC; Yu AYX; Vyas MV; Kapral MK
    Neurology; 2021 Nov; 97(18):856-863. PubMed ID: 34504033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants.
    Allan V; Ramagopalan SV; Mardekian J; Jenkins A; Li X; Pan X; Luo X
    J Comp Eff Res; 2020 Jun; 9(9):603-614. PubMed ID: 32186922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Propensity Scoring and Its Application to Real-World Data: Advantages, Disadvantages, and Methodological Objectives Explained to Researchers Without Using Mathematical Equations.
    Franchetti Y
    J Clin Pharmacol; 2022 Mar; 62(3):304-319. PubMed ID: 34671990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weighting.
    Prats-Uribe A; Kolovos S; Berencsi K; Carr A; Judge A; Silman A; Arden N; Petersen I; Douglas IJ; Wilkinson JM; Murray D; Valderas JM; Beard DJ; Lamb SE; Ali MS; Pinedo-Villanueva R; Strauss VY; Prieto-Alhambra D
    Health Technol Assess; 2021 Nov; 25(66):1-126. PubMed ID: 34812138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity score weighting under limited overlap and model misspecification.
    Zhou Y; Matsouaka RA; Thomas L
    Stat Methods Med Res; 2020 Dec; 29(12):3721-3756. PubMed ID: 32693715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best (but oft-forgotten) practices: propensity score methods in clinical nutrition research.
    Ali MS; Groenwold RH; Klungel OH
    Am J Clin Nutr; 2016 Aug; 104(2):247-58. PubMed ID: 27413128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world propensity score comparison of treatment effectiveness of peginterferon beta-1a vs. subcutaneous interferon beta-1a, glatiramer acetate, and teriflunomide in patients with relapsing-remitting multiple sclerosis.
    Reder AT; Arndt N; Roman C; Geremakis C; Mendoza JP; Su R; Makin C; Avila RL; Vignos MC
    Mult Scler Relat Disord; 2021 Jun; 51():102935. PubMed ID: 33882426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vector-based kernel weighting: A simple estimator for improving precision and bias of average treatment effects in multiple treatment settings.
    Garrido MM; Lum J; Pizer SD
    Stat Med; 2021 Feb; 40(5):1204-1223. PubMed ID: 33327037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addressing substantial covariate imbalance with propensity score stratification and balancing weights: connections and recommendations.
    Thomas LE; Thomas SM; Li F; Matsouaka RA
    Epidemiol Methods; 2023 Jan; 12(1):20220131. PubMed ID: 38013684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dimensional propensity score algorithm in comparative effectiveness research with time-varying interventions.
    Neugebauer R; Schmittdiel JA; Zhu Z; Rassen JA; Seeger JD; Schneeweiss S
    Stat Med; 2015 Feb; 34(5):753-81. PubMed ID: 25488047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Propensity-Score Methods and Their Use in Cardiovascular Research.
    Deb S; Austin PC; Tu JV; Ko DT; Mazer CD; Kiss A; Fremes SE
    Can J Cardiol; 2016 Feb; 32(2):259-65. PubMed ID: 26315351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies.
    Elze MC; Gregson J; Baber U; Williamson E; Sartori S; Mehran R; Nichols M; Stone GW; Pocock SJ
    J Am Coll Cardiol; 2017 Jan; 69(3):345-357. PubMed ID: 28104076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
    Lefort M; Sharmin S; Andersen JB; Vukusic S; Casey R; Debouverie M; Edan G; Ciron J; Ruet A; De Sèze J; Maillart E; Zephir H; Labauge P; Defer G; Lebrun-Frenay C; Moreau T; Berger E; Clavelou P; Pelletier J; Stankoff B; Gout O; Thouvenot E; Heinzlef O; Al-Khedr A; Bourre B; Casez O; Cabre P; Montcuquet A; Wahab A; Camdessanché JP; Maurousset A; Ben Nasr H; Hankiewicz K; Pottier C; Maubeuge N; Dimitri-Boulos D; Nifle C; Laplaud DA; Horakova D; Havrdova EK; Alroughani R; Izquierdo G; Eichau S; Ozakbas S; Patti F; Onofrj M; Lugaresi A; Terzi M; Grammond P; Grand'Maison F; Yamout B; Prat A; Girard M; Duquette P; Boz C; Trojano M; McCombe P; Slee M; Lechner-Scott J; Turkoglu R; Sola P; Ferraro D; Granella F; Shaygannejad V; Prevost J; Maimone D; Skibina O; Buzzard K; Van der Walt A; Karabudak R; Van Wijmeersch B; Csepany T; Spitaleri D; Vucic S; Koch-Henriksen N; Sellebjerg F; Soerensen PS; Hilt Christensen CC; Rasmussen PV; Jensen MB; Frederiksen JL; Bramow S; Mathiesen HK; Schreiber KI; Butzkueven H; Magyari M; Kalincik T; Leray E
    BMC Med Res Methodol; 2022 May; 22(1):155. PubMed ID: 35637426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments.
    Austin PC
    Stat Med; 2014 Mar; 33(7):1242-58. PubMed ID: 24122911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.